Research and Development

Developing in third parties’ high technology and non-infringing Intellectual Properties, often patented technologies, Alvion is an IP powerhouse providing licensing rights to the largest pharmaceutical companies in the world.

The vision of Alvion is to become the most advanced Research and Development independent company in Southern Europe within five years, building its own R&D center for finished dosage products and APIs, developing complex products such as peptides, prolonged release technologies, and fixed combination products.

Entering gradually in the segment of CDMO, Alvion is also offering custom development services as well as regulatory services.

Scroll to Top